Discover more about Merz Therapeutics history
Learn more about our history
Better outcomes for more patients
Who we are
Founded in 1908 by Friedrich Merz, the Merz company was built on a simple belief: progress in healthcare begins by understanding what people truly need. More than a century later, that principle continues to guide Merz Therapeutics as part of the Merz Group.
Today in the United States, Merz Therapeutics is focused on delivering established and innovative therapies for serious neurological conditions. Our ambition is to make a meaningful difference for patients and the healthcare professionals who care for them.
In the spirit of our founder, we approach every new opportunity by asking a single, essential question:
What is needed?
Our vision & mission
Our vision is to be a leading specialty pharmaceutical company focused on neurology — driven by innovation that benefits both patients and society.
Our mission is to deliver better outcomes for more patients. With science as our foundation and the patient experience as our focus, we relentlessly pursue innovative treatments and partnerships to answer unmet needs in specialty neurology.
Our values
Persist in innovation
Innovation is the key to our success and growth. We efficiently identify and relentlessly pursue clinical and strategic developments that will define our future. Our culture of innovation empowers employees by rewarding risk-taking and encouraging accountability.
Commit to customers and colleagues
We build lasting relationships between ourselves and our partners, based on trust, respect and integrity. We live by an open, collegial company culture, and actively seek feedback from our partners to make our relationships the best they can be.
Deliver trusted results
We are proud to continue Merz’s long-standing legacy of high quality and scientifically backed products. We are trusted because our high ethical standards demand that we keep our promises to every partner, customer and patient. Our long-term mindset commits us to delivering profitability and financial sustainability for years to come.
Putting patients first
At Merz Therapeutics, patients are at the center of everything we do. We focus our efforts on conditions that can profoundly affect independence, function and quality of life — areas where unmet needs remain and where meaningful progress can make a real difference.
Across our portfolio, we are committed to advancing therapies that address complex needs, including:
Chronic severe drooling (sialorrhea)
Motor dysfunction
Neurocognitive dysfunction
Neuromuscular disorders and related conditions
Vocal fold insufficiency
Walking disability in multiple sclerosis
Beyond developing therapies, we strive to support patients through education, access initiatives and collaboration with healthcare professionals and patient advocacy groups. Our goal is not only to treat diseases, but to also help people live fuller, more connected lives.
Our impact in the U.S.
Our growing team is the engine of our business, made stronger every day by our recruitment strategy that welcomes a broad range of insights and experiences.
30years
of operation in the U.S.
190+
U.S. employees
7
products commercialized in the U.S.
